iShares U.S. Pharmaceuticals ETF

This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Thursday. It’s the one-year…

Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk rose as much as 4%…

Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug…

A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21,…

Thomas Fuller | Nurphoto | Getty Images Pfizer on Monday said it will seek regulatory approval for a…

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…

Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…

Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…

Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March…

Thursday’s big stock stories: What’s likely to move the market in the next trading session CNBCJ Balvin & More…

5 things to know before the market opens Thursday